Soft-tissue Sarcoma: Clinical Trials

4 trials for Soft-tissue Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 12Unknown 2

Follow Soft-tissue Sarcoma: new trials by email Literature Review of Soft-tissue Sarcoma trials Research Report on Soft-tissue Sarcoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
Phase 1 : Regorafenib, Phase 1 : Avelumab, Phase 2 : Regorafenib - Colorectal Cancer Not MSI-H or MMR-deficient, GIST
Phase 1 / Phase 2UnknownInstitut BergoniƩ7472018-05-042023-03-03
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
Palbociclib - Soft-tissue Sarcoma, Osteosarcoma
Phase 2UnknownGrupo Espanol de Investigacion en Sarcomas402017-03-312024-01-23
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Ribociclib - Liposarcomas, Dedifferentiated, Liposarcoma - Well Differentiated
Phase 2UnknownAssaf-Harofeh Medical Center302016-07-012017-10-25
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
Cyclophosphamide and JX-594 dose escalation, Cyclophosphamide and JX-594, Cyclophosphamide - Solid Tumors, Soft-tissue Sarcoma
Phase 1 / Phase 2UnknownInstitut BergoniƩ1972015-09-182022-02-02

Narrower conditions

Sarcoma (4)  ·  Biliary Tract Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Chordoma (1)  ·  Gastro-enteropancreatic neuroendocrine tumor (1)  ·  Lipoma (1)  ·  Liposarcoma (1)  ·  Liposarcoma, Myxoid (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasm Metastasis (1)  ·  Osteosarcoma (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Breast Diseases (2)  ·  Neoplasms by Site (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adenocarcinoma (1)  ·  Adenoma (1)  ·  Biliary Tract Diseases (1)  ·  Breast Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Digestive System Diseases (1)

Interventions

Clinical Trials, Phase II as Topic (1)  ·  Cyclophosphamide (1)  ·  avelumab (1)  ·  palbociclib (1)  ·  regorafenib (1)  ·  ribociclib (1)

Sponsors

Institut BergoniĆ© (2)  ·  Assaf-Harofeh Medical Center (1)  ·  Grupo Espanol de Investigacion en Sarcomas (1)

Countries

France (2)  ·  Israel (1)  ·  Spain (1)

Top investigators

Anna Estival (1)  ·  Antonio Casado (1)  ·  Claudia Valverde (1)  ·  Daniela Katz, M.D (1)  ·  Diego Jara, MD (1)  ·  Isabel Sevilla, MD (1)  ·  Javier Lavernia (1)  ·  Josefina Cruz (1)

Results publications

PMID 34965951, PMID 34998048, PMID 40204996, PMID 40579407

NIH funding

2014 (1), 2016 (1)